Warby Parker Inc. (WRBY)
NYSE: WRBY · IEX Real-Time Price · USD
16.53
+0.39 (2.42%)
May 17, 2024, 4:00 PM EDT - Market closed

Company Description

Warby Parker Inc. provides eyewear products in the United States and Canada.

The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses.

It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps.

In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Warby Parker Inc.
Warby Parker logo
Country United States
Founded 2010
IPO Date Sep 29, 2021
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 3,491
CEO Neil Harris Blumenthal

Contact Details

Address:
233 Spring Street, 6th Floor East
New York, New York 10013
United States
Phone (646) 847-7215
Website warbyparker.com

Stock Details

Ticker Symbol WRBY
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
IPO Price $40.00
CIK Code 0001504776
CUSIP Number 93403J106
ISIN Number US93403J1060
Employer ID 80-0423634
SIC Code 3851

Key Executives

Name Position
Neil Harris Blumenthal Co-Founder, President, Co-Chief Executive Officer and Co-Chair
David Abraham Gilboa Co-Founder, Co-Chief Executive Officer and Co-Chair
Andrew M. Hunt Co-Founder and Independent Director
Jeff Raider Co-Founder and Independent Director
Steve Miller Senior Vice President, Chief Financial Officer and Treasurer
Jeffrey Saunders Senior Vice President and Chief Technology Officer
Jaclyn Berkley Head of Investor Relations
Chris Utecht Vice President, Head of Legal and Secretary
Lori Krauss Senior Vice President and Chief Marketing Officer
Chelsea Kaden Senior Vice President and Chief People Officer

Latest SEC Filings

Date Type Title
May 17, 2024 144 Filing
May 10, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
May 9, 2024 10-Q Quarterly Report
May 9, 2024 8-K Current Report
Apr 25, 2024 ARS Filing
Apr 25, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 25, 2024 DEF 14A Other definitive proxy statements
Mar 11, 2024 144 Filing
Mar 8, 2024 144 Filing
Mar 7, 2024 144 Filing